BioNTech has won a five-year contract with the German health ministry to produce and supply mRNA vaccines in emergency situations in the country, the Germany-based biotechnology company said on Friday.
Under the framework agreement, BioNTech would reserve and maintain manufacturing capabilities to produce at least 80 million mRNA-based vaccine doses each year to address potential public health threats, the company said in a statement.
"There is growing evidence that viral pandemics will continue to pose a public health challenge for years," said Sean Marett, BioNTech's chief business and chief commercial officer.
BioNTech did not specify any financial details of the agreement.
https://finance.yahoo.com/news/biontech-wins-5-mrna-vaccine-132759780.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.